Fluidichem
Fluidichem is a biotechnology company specializing in revolutionizing drug development through the integration of continuous flow chemistry, automation, and artificial intelligence (AI). Their core offering is a high-throughput automated synthesis robot that accelerates the creation of molecule libraries. This technology allows for rapid synthesis, identification of optimal conditions, and access to unique molecules. Fluidichem supports drug development across all phases, from discovery through pre-clinical and clinical studies, by optimizing reactions and facilitating seamless scale-up. Their CEO, Eric Wimmer, has a strong background in organic chemistry and extensive experience in flow chemistry, automation, and the pharmaceutical industry. The company's services are tailored for the chemical and pharmaceutical industries, aiming to increase speed, efficiency, and reduce waste and costs.
Fluidichem
Fluidichem is a biotechnology company specializing in revolutionizing drug development through the integration of continuous flow chemistry, automation, and artificial intelligence (AI). Their core offering is a high-throughput automated synthesis robot that accelerates the creation of molecule libraries. This technology allows for rapid synthesis, identification of optimal conditions, and access to unique molecules. Fluidichem supports drug development across all phases, from discovery through pre-clinical and clinical studies, by optimizing reactions and facilitating seamless scale-up. Their CEO, Eric Wimmer, has a strong background in organic chemistry and extensive experience in flow chemistry, automation, and the pharmaceutical industry. The company's services are tailored for the chemical and pharmaceutical industries, aiming to increase speed, efficiency, and reduce waste and costs.